Sentence examples for incremental benefit for from inspiring English sources

Additionally, these new investigations have not identified any clinically significant incremental benefit for IOLs which filter only UVR.

In the basecase analysis it was assumed that the recurrence curves continued to show incremental benefit for anastrozole out to 10 years from initiation of treatment.

Our view in summary therefore is that there is no current evidence to suggest an incremental benefit for routine ECG assessment of ADHD patients prior to initiation of medication.

The trend over the past decade of continued price escalation for devices, and the primary technology focus on cementless devices without evident incremental benefit for most patients, compounds the concern that manufacturers are excessively influencing the choice of therapies.

In this context the prospective assessment of patient reported toxicity and quality of life (QL) incorporated in TACT is particularly important although its relevance extends to other clinical scenarios where a small incremental benefit for taxane based regimens has been seen [1].

From a nationwide study focused on 43 000 bystander-witnessed OHCAs of non-cardiac origin, we demonstrated that conventional CPR with rescue breathing had an incremental benefit for OHCAs of non-cardiac origin, but the impact on overall survival after OHCA was small.

An incrementally deployable protocol should have three properties: initial benefits for early adopters, incremental benefits for subsequent adopters, and effectiveness under partial deployment.

It is conceivable that the integration of these ideal markers into clinical practice can provide incremental benefits for targeted treatment, improve prognosis, and reduce hospitalization cost.

Having ranked the comparators by increasing cost, we estimated the incremental cost effectiveness ratios (the ratios of the mean incremental costs to the mean incremental benefits) for the three pairwise comparisons.

More targeted and multiparameter studies are needed to evaluate the efficacy, safety, and incremental benefit of UVGI for mitigating reservoirs of microorganisms and ultimately preventing cross-transmission of pathogens that lead to health care-associated infections.

Based on the data from Liberato et al, trastuzumab led to an incremental benefit of $10,834.07, for which the 95% confidence interval ranged from a cost of $12,797.05 to a benefit of $33,982.92 in the United States setting.